Evidenskort
Kappsýki: hvat vísindini siga
17 útgávur, 4 av teimum royndir og 8 samansetingar. Hesin síða lýsir formið á hesum frásøgnum heldur enn at samanfatta niðurstøðurnar.
Hvat hetta litteratur er gjort av
Samansetingin er á odda fyri primera litteraturinum her — yvirlit og meta-analyser, ið byggja á eitt modest antal av undirliggjandi studium. Beina tryggar niðurstøður við varsemi, sum sample størrelsen krevur.
Skilnaðurin, sum hevur mest at siga, er millum samanseting og primær rannsókn. Ein meta-analyse samlar royndir og er nærmasta tingið til ein avgreiddan svar, sum ein øki framleiðir. Ein narrativt yvirlit er ein bólkur lesing av sama materialinum og kann vera valfrítt uttan at vera óheiðarlegt. At telja tey saman, sum flestu tilvísingar telja, skýrir júst tað, tú vilt vita.
Hvussu hesa síðu er bygda
Alt ovanfyri er útreiknað út frá tilvísingunum, sum henda síða høvdi frá PubMed og Crossref, ikki skrivað við hond. Tá vikuliga høvdið finnur eitt nýtt papir um hetta evnið, broytast hesi tal og karakteriseringen broytist við teimum. Tað er punktið: ein hand-skrivað áheitan um hvussu sterk eitt evidensgrundlag er byrjar at decay dagin tað er skrivað.
Publikationartypur er tikin sum keldan skrásetur tað. Tað er ófullkomið — tímar merkja ósamstøtt, og eitt papir indexerað sum ein "yvirlit" kann vera eitt systematiskt eitt — so viðger bólkarnar sum umleið. Tey eru nóg væl at greina ein royndarlitteratur frá einum viðmerkingarlitteratur, sum er skilnaðurin, sum hevur mest at siga.
Tað sterkasta arbeiðið um hetta evnið
Raðfest eftir royndarupplag fyrst, so nýggjleiki. Heila settið er listað í tilvísingunum niðanfyri.
- Scopolamine til sjúklingar við kynsýki: eitt systematisk yvirlit og meta-analyse við royndar sekventiell greining — Zhang YX, Niu XY, Xiao ZY et al., 2024, meta-analyse
- Uppdatering um PONV-Hvat er nýtt í fyribyrging og viðgerð av eftirskurðarkvalma og brek? : Samandráttur av nýggjum samtyktum og Cochrane yvirlitum um fyribyrging og viðgerð av eftirskurðarkvalma og brek — Kienbaum P, Schaefer MS, Weibel S et al., 2022, meta-analyse
- Antihistaminir til kynsýki — Karrim N, Byrne R, Magula N et al., 2022, systematisk yvirlit
- Mal de debarquement syndrom: eitt systematisk yvirlit — Van Ombergen A, Van Rompaey V, Maes LK et al., 2016, systematisk yvirlit
- Scopolamine (hyoscine) til at fyribyrgja og viðgera kynsýki — Spinks A, Wasiak J, 2011, meta-analyse
- Scopolamine (hyoscine) til at fyribyrgja og viðgera kynsýki — Spinks AB, Wasiak J, Villanueva EV et al., 2007, systematisk yvirlit
- Scopolamine til at fyribyrgja og viðgera kynsýki — Spinks AB, Wasiak J, Villanueva EV et al., 2004, systematisk yvirlit
- Uttalelse um kynsýki — Ótald, 2003, klinisk leiðbeining
- Virtual reality applikatión samsvarar við mest viðurkennda viðgerðina fyri Mal de Debarquement Syndrom: Ein ikki-vanlig, randomiserad, opin klinisk roynd — Schoenmaekers C, De Smet D, Deblieck C et al., 2024, randomiserad kontrollerað roynd
- Double-blind randomiserad N-of-1 roynd av transkranial alternativur nútímans stimulering fyri mal de débarquement syndrom — Cha YH, Gleghorn D, Doudican BC, 2022, randomiserad kontrollerað roynd
Hvussu nógv gransking er um kynsýki?
Betyr meira gransking ein sterkari niðurstøðu?
Hvussu nútímans er hetta?
Hví sigur henda síða ikki mær svarið?
Viðmerkingar
Hver einasta tilvísing niðanfyri bendir til upprunaliga peer-reviewed skjalið á PubMed ella gjøgnum DOI. Einki her er ein staðfesting fyri læknaligt ráð.
-
Scopolamine for patients with motion sickness: a systematic review and meta-analysis with trial sequential analysis Zhang YX, Niu XY, Xiao ZY, et al. · Acta oto-laryngologica · 2024 · Meta-analysis DOIPubMed 39225593
-
Antihistamines for motion sickness Karrim N, Byrne R, Magula N, et al. · The Cochrane database of systematic reviews · 2022 · Systematic review DOIPubMed 36250781Full text
-
[Update on PONV-What is new in prophylaxis and treatment of postoperative nausea and vomiting? : Summary of recent consensus recommendations and Cochrane reviews on prophylaxis and treatment of postoperative nausea and vomiting] Kienbaum P, Schaefer MS, Weibel S, et al. · Der Anaesthesist · 2022 · Meta-analysis DOIPubMed 34596699
-
Mal de debarquement syndrome: a systematic review Van Ombergen A, Van Rompaey V, Maes LK, et al. · Journal of neurology · 2016 · Systematic review DOIPubMed 26559820Full text
-
Scopolamine (hyoscine) for preventing and treating motion sickness Spinks A, Wasiak J · The Cochrane database of systematic reviews · 2011 · Meta-analysis DOIPubMed 21678338Full text
-
Scopolamine (hyoscine) for preventing and treating motion sickness Spinks AB, Wasiak J, Villanueva EV, et al. · The Cochrane database of systematic reviews · 2007 · Systematic review DOIPubMed 17636710
-
Scopolamine for preventing and treating motion sickness Spinks AB, Wasiak J, Villanueva EV, et al. · The Cochrane database of systematic reviews · 2004 · Systematic review DOIPubMed 15266468
-
Statement on motion sickness Canada communicable disease report = Releve des maladies transmissibles au Canada · 2003 · Clinical guideline PubMed 14655530
-
A comparison of virtual reality and verbal imaginal exposure for childhood anxiety disorders Biggs BK, Whiteside SPH, Knutson M, et al. · Journal of anxiety disorders · 2025 · Randomised controlled trial DOIPubMed 39879857Full text
-
Virtual reality application matches the most established treatment for Mal de Debarquement Syndrome: A non-inferiority, randomized, open clinical trial Schoenmaekers C, De Smet D, Deblieck C, et al. · Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024 · Randomised controlled trial DOIPubMed 38942708Full text
-
Double-blind randomized N-of-1 trial of transcranial alternating current stimulation for mal de débarquement syndrome Cha YH, Gleghorn D, Doudican BC · PloS one · 2022 · Randomised controlled trial DOIPubMed 35120184Full text
-
Double-Blind Sham-Controlled Crossover Trial of Repetitive Transcranial Magnetic Stimulation for Mal de Debarquement Syndrome Cha YH, Deblieck C, Wu AD · Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2016 · Randomised controlled trial DOIPubMed 27176615Full text
-
A comparison of cinnarizine and transdermal scopolamine for the prevention of seasickness in naval crew: a double-blind, randomized, crossover study Gil A, Nachum Z, Tal D, et al. · Clinical neuropharmacology · 2012 · Randomised controlled trial DOIPubMed 22139622
-
Incidence of vomiting in susceptible children under regional analgesia with two different anaesthetic techniques Sarti A, Busoni P, Dell'Oste C, et al. · Paediatric anaesthesia · 2004 · Randomised controlled trial DOIPubMed 14996265
-
Chlorpheniramine for motion sickness Buckey JC, Alvarenga D, Cole B, et al. · Journal of vestibular research : equilibrium & orientation · 2004 · Randomised controlled trial PubMed 15156097
-
A comparison of cyclizine, ondansetron and placebo as prophylaxis against postoperative nausea and vomiting in children O'Brien CM, Titley G, Whitehurst P · Anaesthesia · 2003 · Randomised controlled trial DOIPubMed 12886917
-
Effect of timing of ondansetron administration on incidence of postoperative vomiting in paediatric strabismus surgery Madan R, Perumal T, Subramaniam K, et al. · Anaesthesia and intensive care · 2000 · Randomised controlled trial DOIPubMed 10701032
-
Prophylactic therapy with combined granisetron and dexamethasone for the prevention of post-operative vomiting in children Fujii Y, Saitoh Y, Tanaka H, et al. · European journal of anaesthesiology · 1999 · Randomised controlled trial DOIPubMed 10434165
-
Prevention of postoperative vomiting with granisetron in paediatric patients with and without a history of motion sickness Fujii Y, Saitoh Y, Tanaka H, et al. · Paediatric anaesthesia · 1999 · Randomised controlled trial DOIPubMed 10597557
-
The Neurophysiology and Treatment of Motion Sickness Koch A, Cascorbi I, Westhofen M, et al. · Deutsches Arzteblatt international · 2018 · Review DOIPubMed 30406755Full text